Ipratropium Bromide — $0 with Membership

About Ipratropium Bromide

Ipratropium bromide is a widely used medication that helps millions manage various respiratory conditions, improving their quality of life. For those seeking consistent relief without the financial strain, TheDrugClub offers an innovative solution. Our members can access essential medications like ipratropium bromide with a $0 co-pay and the convenience of free home delivery.

Ipratropium bromide is a medication primarily used to treat certain respiratory conditions, helping individuals breathe more easily. It comes in various forms, most commonly as an inhaler (metered-dose inhaler or nebulizer solution) and sometimes as a nasal spray.

What Ipratropium Bromide Treats

The primary use of inhaled ipratropium bromide is for the maintenance treatment of bronchospasm associated with Chronic Obstructive Pulmonary Disease (COPD), including chronic bronchitis and emphysema. It can also be used in conjunction with other bronchodilators for asthma in some cases. By opening the airways, it helps reduce symptoms like wheezing, shortness of breath, and coughing, making daily activities more manageable. As a nasal spray, it's prescribed to alleviate runny nose (rhinorrhea) associated with the common cold or allergic rhinitis.

How Ipratropium Bromide Works

Ipratropium bromide belongs to a class of drugs called anticholinergics. When inhaled, it works by blocking the action of acetylcholine, a natural chemical in the body that can cause the smooth muscles around the airways to constrict. By blocking these receptors in the lungs, ipratropium bromide helps to relax the muscles, widening the air passages and making it easier to breathe. It's important to note that while it provides sustained relief, it is not a "rescue inhaler" for immediate relief of acute breathing problems but rather a maintenance medication used regularly to prevent symptoms.

Typical Costs for Ipratropium Bromide

The cost of ipratropium bromide can vary significantly depending on its form (inhaler, nebulizer solution, or nasal spray), dosage, and whether it's a generic or brand-name product. Without insurance, a month's supply can range anywhere from $30 to over $100, and even with insurance, co-pays can add up, especially for chronic conditions requiring long-term use. These fluctuating costs can be a major barrier for many, leading to skipped doses or rationing medication, which can severely impact health.

Get Your Ipratropium Bromide for $0 Co-

The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.

What Ipratropium Bromide is approved for (FDA label)

Ipratropium Bromide Inhalation Solution administered either alone or with other bronchodilators, especially beta adrenergics, is indicated as a bronchodilator for maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema.

Source: Read the full FDA label on DailyMed. Label effective date: July 24, 2026.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Ipratropium Bromide (FDA label)

Adverse reaction information concerning ipratropium bromide inhalation solution is derived from 12-week active-controlled clinical trials. Additional information is derived from foreign post-marketing experience and the published literature. All adverse events, regardless of drug relationship, reported by three percent or more patients in the 12-week controlled clinical trials appear in the table below. Additional adverse reactions reported in less than three percent of the patients treated with ipratropium bromide include tachycardia, palpitations, eye pain, urinary retention, urinary tract infection and urticaria. Cases of precipitation or worsening of narrow-angle glaucoma, mydriasis, and acute eye pain have been reported. Lower respiratory adverse reactions (bronchitis, dyspnea and bronchospasm) were the most common events leading to discontinuation of ipratropium bromide therapy in the 12-week trials.

Source: FDA prescribing information (DailyMed). Set ID: 6b730dd7-4d93-403a-bfd2-fa0efa298b75. Label effective date: July 24, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Contraindications for Ipratropium Bromide (FDA label)

Ipratropium bromide is contraindicated in known or suspected cases of hypersensitivity to ipratropium bromide, or to atropine and its derivatives.

Source: FDA prescribing information (DailyMed). Set ID: 6b730dd7-4d93-403a-bfd2-fa0efa298b75. Label effective date: July 24, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Drug interactions for Ipratropium Bromide (FDA label)

Ipratropium bromide has been shown to be a safe and effective bronchodilator when used in conjunction with beta adrenergic bronchodilators. Ipratropium bromide has also been used with other pulmonary medications, including methylxanthines and corticosteroids, without adverse drug interactions.

Source: FDA prescribing information (DailyMed). Set ID: 6b730dd7-4d93-403a-bfd2-fa0efa298b75. Label effective date: July 24, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.